Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age

Similar articles for PMID: 2198122

Showing 1 to 12 of 95 entries
Sorted by: Best Match Show Resources per page
Intravenous hyperimmune globulin prophylaxis against cytomegalovirus interstitial pneumonitis after allogenic bone marrow transplantation.

The Tokai journal of experimental and clinical medicine

Jacobsen N, Schäfer U, Ostendorf P, Kubaneck B, Wolf H.
PMID: 3010510
Tokai J Exp Clin Med. 1985 Jun;10(2):193-5.

In an attempt to reduce the incidence of lethal cytomegalovirus (CMV) interstitial pneumonitis after allogenic bone marrow transplantation 49 patients were randomized in a multicenter controlled study to receive either CMV-hyperimmune globulin or a control immune globulin with low...

Cite
Jacobsen N, Schäfer U, Ostendorf P, et al. Intravenous hyperimmune globulin prophylaxis against cytomegalovirus interstitial pneumonitis after allogenic bone marrow transplantation. Tokai J Exp Clin Med. 1985;10(2):193-5
Jacobsen, N., Schäfer, U., Ostendorf, P., Kubaneck, B., & Wolf, H. (1985). Intravenous hyperimmune globulin prophylaxis against cytomegalovirus interstitial pneumonitis after allogenic bone marrow transplantation. The Tokai journal of experimental and clinical medicine, 10(2), 193-5.
Jacobsen, N, et al. "Intravenous hyperimmune globulin prophylaxis against cytomegalovirus interstitial pneumonitis after allogenic bone marrow transplantation." The Tokai journal of experimental and clinical medicine vol. 10,2 (1985): 193-5.
Jacobsen N, Schäfer U, Ostendorf P, Kubaneck B, Wolf H. Intravenous hyperimmune globulin prophylaxis against cytomegalovirus interstitial pneumonitis after allogenic bone marrow transplantation. Tokai J Exp Clin Med. 1985 Jun;10(2):193-5. PMID: 3010510.
Copy Download .nbib Format: NLM
The clinical use of intravenous immunoglobulin in pediatrics.

Indian journal of pediatrics

Wahn V.
PMID: 3428982
Indian J Pediatr. 1987 Sep-Oct;54(5):641-53. doi: 10.1007/BF02751271.

No abstract available.

Cite
Wahn V. The clinical use of intravenous immunoglobulin in pediatrics. Indian J Pediatr. 1987;54(5):641-53doi: 10.1007/BF02751271.
Wahn, V. (1987). The clinical use of intravenous immunoglobulin in pediatrics. Indian journal of pediatrics, 54(5), 641-53. https://doi.org/10.1007/BF02751271
Wahn, V. "The clinical use of intravenous immunoglobulin in pediatrics." Indian journal of pediatrics vol. 54,5 (1987): 641-53. doi: https://doi.org/10.1007/BF02751271
Wahn V. The clinical use of intravenous immunoglobulin in pediatrics. Indian J Pediatr. 1987 Sep-Oct;54(5):641-53. doi: 10.1007/BF02751271. PMID: 3428982.
Copy Download .nbib Format: NLM
The use of intravenous immune globulin in immunodeficiency diseases.

The New England journal of medicine

Buckley RH, Schiff RI.
PMID: 2052044
N Engl J Med. 1991 Jul 11;325(2):110-7. doi: 10.1056/NEJM199107113250207.

No abstract available.

Cite
Buckley RH, Schiff RI. The use of intravenous immune globulin in immunodeficiency diseases. N Engl J Med. 1991;325(2):110-7doi: 10.1056/NEJM199107113250207.
Buckley, R. H., & Schiff, R. I. (1991). The use of intravenous immune globulin in immunodeficiency diseases. The New England journal of medicine, 325(2), 110-7. https://doi.org/10.1056/NEJM199107113250207
Buckley, R H, and Schiff, R I. "The use of intravenous immune globulin in immunodeficiency diseases." The New England journal of medicine vol. 325,2 (1991): 110-7. doi: https://doi.org/10.1056/NEJM199107113250207
Buckley RH, Schiff RI. The use of intravenous immune globulin in immunodeficiency diseases. N Engl J Med. 1991 Jul 11;325(2):110-7. doi: 10.1056/NEJM199107113250207. PMID: 2052044.
Copy Download .nbib Format: NLM
[Fc receptor blockade in patients with chronic refractory autoimmune thrombocytopenia].

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion

Ruiz-Argüelles GJ, Ruiz-Argüelles A, Marín-López A.
PMID: 8393212
Rev Invest Clin. 1993 Mar-Apr;45(2):182-3.

No abstract available.

Cite
Ruiz-Argüelles GJ, Ruiz-Argüelles A, Marín-López A. Bloqueo de los receptores Fc en pacientes con trombocitopenia autoinmune refractaria crónica. [Fc receptor blockade in patients with chronic refractory autoimmune thrombocytopenia]. Rev Invest Clin. 1993;45(2):182-3
Ruiz-Argüelles, G. J., Ruiz-Argüelles, A., & Marín-López, A. (1993). Bloqueo de los receptores Fc en pacientes con trombocitopenia autoinmune refractaria crónica. [Fc receptor blockade in patients with chronic refractory autoimmune thrombocytopenia]. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion, 45(2), 182-3.
Ruiz-Argüelles, G J, et al. "Bloqueo de los receptores Fc en pacientes con trombocitopenia autoinmune refractaria crónica." [Fc receptor blockade in patients with chronic refractory autoimmune thrombocytopenia]. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion vol. 45,2 (1993): 182-3.
Ruiz-Argüelles GJ, Ruiz-Argüelles A, Marín-López A. Bloqueo de los receptores Fc en pacientes con trombocitopenia autoinmune refractaria crónica. [Fc receptor blockade in patients with chronic refractory autoimmune thrombocytopenia]. Rev Invest Clin. 1993 Mar-Apr;45(2):182-3. Spanish. PMID: 8393212.
Copy Download .nbib Format: NLM
Somebody else's antibodies: the characteristics and roles of immune globulins.

Pharmacy practice management quarterly

Grabenstein JD.
PMID: 11291518
Pharm Pract Manag Q. 2001;20(3):41-55; quiz 56-9. doi: 10.1177/001857870003500403.

UNLABELLED: CREDIT: This lesson is good for 0.2 CE units, with a passing grade of 70%.OBJECTIVES: After completing this continuing education article, the pharmacist will be able to: 1. Compare and contrast active vs. passive immunity and homologous vs....

Cite
Grabenstein JD. Somebody else's antibodies: the characteristics and roles of immune globulins. Pharm Pract Manag Q. 2001;20(3):41-55; quiz 56-9doi: 10.1177/001857870003500403.
Grabenstein, J. D. (2001). Somebody else's antibodies: the characteristics and roles of immune globulins. Pharmacy practice management quarterly, 20(3), 41-55; quiz 56-9. https://doi.org/10.1177/001857870003500403
Grabenstein, J D. "Somebody else's antibodies: the characteristics and roles of immune globulins." Pharmacy practice management quarterly vol. 20,3 (2001): 41-55; quiz 56-9. doi: https://doi.org/10.1177/001857870003500403
Grabenstein JD. Somebody else's antibodies: the characteristics and roles of immune globulins. Pharm Pract Manag Q. 2001;20(3):41-55; quiz 56-9. doi: 10.1177/001857870003500403. PMID: 11291518.
Copy Download .nbib Format: NLM
[Intravenous gamma globulin therapy. Measurement of circulating immune complexes and complement factors].

Fortschritte der Medizin

Wahn V.
PMID: 6479819
Fortschr Med. 1984 Aug 30;102(31):795-8.

15 patients with different forms of relevant antibody deficiency syndromes were treated with gammaglobulin (Immunglobulin SRK) by intravenous route. Analysis of the complement system showed a weak activation of the C-system in vivo and a reduction of C-turnover. Prior...

Cite
Wahn V. Intravenöse Gammaglobulin-Therapie. Messung von zirkulierenden Immunkomplexen und Komplementfaktoren. [Intravenous gamma globulin therapy. Measurement of circulating immune complexes and complement factors]. Fortschr Med. 1984;102(31):795-8
Wahn, V. (1984). Intravenöse Gammaglobulin-Therapie. Messung von zirkulierenden Immunkomplexen und Komplementfaktoren. [Intravenous gamma globulin therapy. Measurement of circulating immune complexes and complement factors]. Fortschritte der Medizin, 102(31), 795-8.
Wahn, V. "Intravenöse Gammaglobulin-Therapie. Messung von zirkulierenden Immunkomplexen und Komplementfaktoren." [Intravenous gamma globulin therapy. Measurement of circulating immune complexes and complement factors]. Fortschritte der Medizin vol. 102,31 (1984): 795-8.
Wahn V. Intravenöse Gammaglobulin-Therapie. Messung von zirkulierenden Immunkomplexen und Komplementfaktoren. [Intravenous gamma globulin therapy. Measurement of circulating immune complexes and complement factors]. Fortschr Med. 1984 Aug 30;102(31):795-8. German. PMID: 6479819.
Copy Download .nbib Format: NLM
A new subcutaneous immune globulin (HyQvia) for primary immunodeficiency.

The Medical letter on drugs and therapeutics

[No authors listed]
PMID: 26305523
Med Lett Drugs Ther. 2015 Aug 31;57(1476):121-2.

No abstract available.

Cite
A new subcutaneous immune globulin (HyQvia) for primary immunodeficiency. Med Lett Drugs Ther. 2015;57(1476):121-2
(2015). A new subcutaneous immune globulin (HyQvia) for primary immunodeficiency. The Medical letter on drugs and therapeutics, 57(1476), 121-2.
"A new subcutaneous immune globulin (HyQvia) for primary immunodeficiency." The Medical letter on drugs and therapeutics vol. 57,1476 (2015): 121-2.
A new subcutaneous immune globulin (HyQvia) for primary immunodeficiency. Med Lett Drugs Ther. 2015 Aug 31;57(1476):121-2. PMID: 26305523.
Copy Download .nbib Format: NLM
Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials.

Journal of clinical immunology

Ballow M, Wasserman RL, Jolles S, Chapel H, Berger M, Misbah SA.
PMID: 28695366
J Clin Immunol. 2017 Aug;37(6):517-518. doi: 10.1007/s10875-017-0410-x. Epub 2017 Jul 10.

No abstract available.

Cite
Ballow M, Wasserman RL, Jolles S, et al. Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials. J Clin Immunol. 2017;37(6):517-518doi: 10.1007/s10875-017-0410-x.
Ballow, M., Wasserman, R. L., Jolles, S., Chapel, H., Berger, M., & Misbah, S. A. (2017). Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials. Journal of clinical immunology, 37(6), 517-518. https://doi.org/10.1007/s10875-017-0410-x
Ballow, Mark, et al. "Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials." Journal of clinical immunology vol. 37,6 (2017): 517-518. doi: https://doi.org/10.1007/s10875-017-0410-x
Ballow M, Wasserman RL, Jolles S, Chapel H, Berger M, Misbah SA. Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials. J Clin Immunol. 2017 Aug;37(6):517-518. doi: 10.1007/s10875-017-0410-x. Epub 2017 Jul 10. PMID: 28695366; PMCID: PMC5940704.
Copy Download .nbib Format: NLM
Passively acquired human immunodeficiency virus seropositivity in a neonate after hepatitis B immunoglobulin.

The Journal of pediatrics

Albersheim SG, Smyth JA, Solimano A, Cook D.
PMID: 3373398
J Pediatr. 1988 Jun;112(6):915-6. doi: 10.1016/s0022-3476(88)80215-4.

No abstract available.

Cite
Albersheim SG, Smyth JA, Solimano A, et al. Passively acquired human immunodeficiency virus seropositivity in a neonate after hepatitis B immunoglobulin. J Pediatr. 1988;112(6):915-6doi: 10.1016/s0022-3476(88)80215-4.
Albersheim, S. G., Smyth, J. A., Solimano, A., & Cook, D. (1988). Passively acquired human immunodeficiency virus seropositivity in a neonate after hepatitis B immunoglobulin. The Journal of pediatrics, 112(6), 915-6. https://doi.org/10.1016/s0022-3476(88)80215-4
Albersheim, S G, et al. "Passively acquired human immunodeficiency virus seropositivity in a neonate after hepatitis B immunoglobulin." The Journal of pediatrics vol. 112,6 (1988): 915-6. doi: https://doi.org/10.1016/s0022-3476(88)80215-4
Albersheim SG, Smyth JA, Solimano A, Cook D. Passively acquired human immunodeficiency virus seropositivity in a neonate after hepatitis B immunoglobulin. J Pediatr. 1988 Jun;112(6):915-6. doi: 10.1016/s0022-3476(88)80215-4. PMID: 3373398.
Copy Download .nbib Format: NLM
Immune globulin solubility in 5% dextrose injection.

American journal of hospital pharmacy

Donnelly RF.
PMID: 2121027
Am J Hosp Pharm. 1990 Sep;47(9):1976.

No abstract available.

Cite
Donnelly RF. Immune globulin solubility in 5% dextrose injection. Am J Hosp Pharm. 1990;47(9):1976
Donnelly, R. F. (1990). Immune globulin solubility in 5% dextrose injection. American journal of hospital pharmacy, 47(9), 1976.
Donnelly, R F. "Immune globulin solubility in 5% dextrose injection." American journal of hospital pharmacy vol. 47,9 (1990): 1976.
Donnelly RF. Immune globulin solubility in 5% dextrose injection. Am J Hosp Pharm. 1990 Sep;47(9):1976. PMID: 2121027.
Copy Download .nbib Format: NLM
Intravenous gamma-globulin in infant acquired immunodeficiency syndrome.

Pediatric infectious disease

Calvelli TA, Rubinstein A.
PMID: 3086850
Pediatr Infect Dis. 1986 May-Jun;5(3):S207-10.

No abstract available.

Cite
Calvelli TA, Rubinstein A. Intravenous gamma-globulin in infant acquired immunodeficiency syndrome. Pediatr Infect Dis. 1986;5(3):S207-10
Calvelli, T. A., & Rubinstein, A. (1986). Intravenous gamma-globulin in infant acquired immunodeficiency syndrome. Pediatric infectious disease, 5(3), S207-10.
Calvelli, T A, and Rubinstein, A. "Intravenous gamma-globulin in infant acquired immunodeficiency syndrome." Pediatric infectious disease vol. 5,3 (1986): S207-10.
Calvelli TA, Rubinstein A. Intravenous gamma-globulin in infant acquired immunodeficiency syndrome. Pediatr Infect Dis. 1986 May-Jun;5(3):S207-10. PMID: 3086850.
Copy Download .nbib Format: NLM
Clinical uses of intravenous immunoglobulins.

Annals of internal medicine

Berkman SA, Lee ML, Gale RP.
PMID: 2404449
Ann Intern Med. 1990 Feb 15;112(4):278-92. doi: 10.7326/0003-4819-112-4-278.

PURPOSE: To ascertain the activity of intravenous immunoglobulin in a wide range of diseases.DATA IDENTIFICATION: English-language literature search using MEDLINE (1982 to 89), review of meeting reports, and extensive hand searching of bibliographies of identified articles.STUDY SELECTION: All identified...

Cite
Berkman SA, Lee ML, Gale RP. Clinical uses of intravenous immunoglobulins. Ann Intern Med. 1990;112(4):278-92doi: 10.7326/0003-4819-112-4-278.
Berkman, S. A., Lee, M. L., & Gale, R. P. (1990). Clinical uses of intravenous immunoglobulins. Annals of internal medicine, 112(4), 278-92. https://doi.org/10.7326/0003-4819-112-4-278
Berkman, S A, et al. "Clinical uses of intravenous immunoglobulins." Annals of internal medicine vol. 112,4 (1990): 278-92. doi: https://doi.org/10.7326/0003-4819-112-4-278
Berkman SA, Lee ML, Gale RP. Clinical uses of intravenous immunoglobulins. Ann Intern Med. 1990 Feb 15;112(4):278-92. doi: 10.7326/0003-4819-112-4-278. PMID: 2404449.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 95 entries